» Articles » PMID: 20599770

86Rb+ Efflux Mediated by Alpha4beta2*-nicotinic Acetylcholine Receptors with High and Low-sensitivity to Stimulation by Acetylcholine Display Similar Agonist-induced Desensitization

Overview
Date 2010 Jul 6
PMID 20599770
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The nicotinic acetylcholine receptors (nAChR) assembled from alpha4 and beta2 subunits are the most densely expressed subtype in the brain. Concentration-effect curves for agonist activation of alpha4beta2*-nAChR are biphasic. This biphasic agonist sensitivity is ascribed to differences in subunit stoichiometry. The studies described here evaluated desensitization elicited by low concentrations of epibatidine, nicotine, cytisine or methylcarbachol of brain alpha4beta2-nAChR function measured with acetylcholine-stimulated (86)Rb(+) efflux from mouse thalamic synaptosomes. Each agonist elicited concentration-dependent desensitization. The agonists differed in potency. However, IC(50) values for each agonist for desensitization of (86)Rb(+) efflux both with high (EC(50) approximately 3 microM) and low (EC(50) approximately 150 microM) acetylcholine sensitivity were not significantly different. Concentrations required to elicit desensitization were higher that their respective K(D) values for receptor binding. Even though the two components of alpha4beta2*-nAChR-mediated (86)Rb(+) efflux from mouse brain differ markedly in EC(50) values for agonist activation, they are equally sensitive to desensitization by exposure to low agonist concentrations. Mice were also chronically treated with nicotine by continuous infusion of 0, 0.5 or 4.0mg/kg/h and desensitization induced by nicotine was evaluated. Consistent with previous results, chronic nicotine treatment increased the density of epibatidine binding sites. Acute exposure to nicotine also elicited concentration-dependent desensitization of both high-sensitivity and low-sensitivity acetylcholine-stimulated (86)Rb(+) efflux from cortical and thalamic synaptosomes. Although chronic nicotine treatment reduced maximal (86)Rb(+) efflux from thalamus, IC(50) values in both brain regions were unaffected by chronic nicotine treatment.

Citing Articles

Population Pharmacodynamic Models of Risperidone on PANSS Total Scores and Prolactin Levels in Schizophrenia.

Huang Z, Zhang L, Li Y, Yu Y, Shen Y, Sun X Pharmaceuticals (Basel). 2024; 17(2).

PMID: 38399363 PMC: 10891722. DOI: 10.3390/ph17020148.


Acute effects of the imidacloprid metabolite desnitro-imidacloprid on human nACh receptors relevant for neuronal signaling.

Loser D, Grillberger K, Hinojosa M, Blum J, Haufe Y, Danker T Arch Toxicol. 2021; 95(12):3695-3716.

PMID: 34628512 PMC: 8536575. DOI: 10.1007/s00204-021-03168-z.


Functional alterations by a subgroup of neonicotinoid pesticides in human dopaminergic neurons.

Loser D, Hinojosa M, Blum J, Schaefer J, Brull M, Johansson Y Arch Toxicol. 2021; 95(6):2081-2107.

PMID: 33778899 PMC: 8166715. DOI: 10.1007/s00204-021-03031-1.


The α5 Nicotinic Acetylcholine Receptor Subunit Differentially Modulates α4β2 and α3β4 Receptors.

Scholze P, Huck S Front Synaptic Neurosci. 2020; 12:607959.

PMID: 33343327 PMC: 7744819. DOI: 10.3389/fnsyn.2020.607959.


Nicotinic Acetylcholine Receptor Accessory Subunits Determine the Activity Profile of Epibatidine Derivatives.

Corrie L, Stokes C, Wilkerson J, Carroll F, McMahon L, Papke R Mol Pharmacol. 2020; 98(4):328-342.

PMID: 32690626 PMC: 7485586. DOI: 10.1124/molpharm.120.000037.


References
1.
Quick M, Lester R . Desensitization of neuronal nicotinic receptors. J Neurobiol. 2002; 53(4):457-78. DOI: 10.1002/neu.10109. View

2.
Rollema H, Coe J, Chambers L, Hurst R, Stahl S, Williams K . Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation. Trends Pharmacol Sci. 2007; 28(7):316-25. DOI: 10.1016/j.tips.2007.05.003. View

3.
Rowell P, Li M . Dose-response relationship for nicotine-induced up-regulation of rat brain nicotinic receptors. J Neurochem. 1997; 68(5):1982-9. DOI: 10.1046/j.1471-4159.1997.68051982.x. View

4.
Perry D, Davila-Garcia M, Stockmeier C, Kellar K . Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J Pharmacol Exp Ther. 1999; 289(3):1545-52. View

5.
Sharp B, Beyer H . Rapid desensitization of the acute stimulatory effects of nicotine on rat plasma adrenocorticotropin and prolactin. J Pharmacol Exp Ther. 1986; 238(2):486-91. View